Last updated on December 2018

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)


Brief description of study

In this part of the Registry Program patients with non-valvular atrial fibrillation (AF) at risk for stroke are enrolled to characterize the target population and to collect real world data on important outcome events. For administrative purposes the study is divided into two protocol numbers: 1160.129 for non-EU (European Union) and non-EEA (European Economic Area) countries, and 1160.136 for EU and EEA countries. The total number of patients enrolled in both protocols is estimated to be 48,000 patients, and all these patients will be included in the data analysis for study 1160.129.

Clinical Study Identifier: NCT01671007

Contact Investigators or Research Sites near you

Start Over

Boehringer Ingelheim Call Center

Praxis Dr. Claus, 10969 Berlin
Berlin, Germany
8.44miles